MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05278nam a2200349 i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MY-KuUP |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251125105945.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
a||||fr|||| 001 0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
ta |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220223t20212021my a|||fram|| 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
THE0009212(Local) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UMP |
| Language of cataloging |
eng |
| Transcribing agency |
UMP |
| Description conventions |
rda |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
|---|
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
FIST .O83 2021 r Thesis |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Osama Abdulmunem Khayri Al-Obaidi, |
| Relator term |
author. |
| 245 14 - TITLE STATEMENT |
|---|
| Title |
The effect of antidiabetic activity of eurycoma longifolia, orthosiphon stamineus and punica granatum combined extracts on streptozotocin-induced diabetic rats / |
| Statement of responsibility, etc. |
Osama Abdulmunem Khayri Al-Obaidi |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Kuantan, Pahang : |
| Name of producer, publisher, distributor, manufacturer |
UMP, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2021 |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
© 2021 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xvi, 112 pages : |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
30 cm. + |
| Accompanying material |
1 CD ROM. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Faculty of Industrial Sciences and Technology |
| 502 ## - DISSERTATION NOTE |
|---|
| Dissertation note |
Thesis (Doctor of Philosophy) -- Universiti Malaysia Pahang – 2020 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Diabetes mellitus (DM) is a metabolic syndrome that is currently being managed using different brands of prescribed medications; however, these medications are associated with different side effects. As such, medical plants are considered an alternative in traditional medicines for treating DM as they have no side effects. The present study was conceived with the aim of studying generally medicinal plants extracts in terms of their 𝛼-amylase and 𝛼-glucosidase inhibitory activities; to study the renal, hepatic, and pancreatic protective effects of these ElE:OsC (2:1) and ElE:PgC (2:1) plant extracts on streptozotocin (STZ)-induced diabetic rats after 30 days of treatment. Sprague-Dawley rats were intraperitoneally injected with STZ (60 mg/kg) to induce DM. The rats were randomly grouped into 7 groups of 5 rats each based on the intended treatment for the groups; the seven groups of rats are as follows: NC = normal control rats; NElE:PgC (2:1) = normal rats treated with combined E. longifolia and P. granatum extracts at a combination ratio of 2:1 (200 mg/kg); NElE:OsC (2:1) = normal rats treated with combined extracts of E. longifolia and O. stamineus at 2:1 combination ratio; DC = diabetic control rats; DG = glibenclamide (0.6 mg/kg)-treated diabetic rats; DElE:PgC (2:1) = diabetic rats treated with combined extracts of E. longifolia and P. granatum at a ratio of 2:1 (200 mg/kg); DElE:OsC (2:1) = diabetic rats treated with combined extracts of E. longifolia and O. stamineus at the same ratio. All the animal groups were treated for 4 weeks and after the treatment period, the blood glucose level, body weight, liver and renal functions, and histopathological changes of the endocrine pancreas, liver and kidneys were examined in all the experimental rats. The extracts with ≥ 50% enzyme inhibition activity were reported in A. bilimbi, A. paniculata, O. stamineus, E. longifolia and P. granatum. The outcome of the study showed that a 2:1 combination of ethanolic extract of E. longifolia and chloroform extract of P. granatum showed gave the maximum rate of α-glucosidase inhibition (148.06%), while a similar combination of ethanol extract of E. longifolia and chloroform extract of O. stamineus offered the greatest α-glucosidase inhibition (137.43%). GC-MS-based phytochemical analysis of the extracts showed the presence of fatty acids in the extracts, with palmitic acid being the highest occurring fatty acid in the extracts of O. stamineus. Results showed a significantly increase (p<0.05) in fasting blood glucose level, body weight, AST, ALT, ALP and GGT levels, total protein, albumin, globulin, blood urea level and serum creatinine level in the DC group compared to the NC group. However, changes in these parameters were ameliorated in the DElE:OsC (2:1), DElE:PgC (2:1) and DG groups; the ameliorative effect was significant in the DG and DElE:PgC (2:1) groups only (p<0.05). Examination of the liver sections showed mild vacuolation in the cytoplasm of the hepatocytes, congestion in the central vein, portal vein and sinusoid, as well as mild hepatic cord disarrangement in the DC group. These pathological changes were ameliorated in the ElE:OsC (2:1), ElE:PgC (2:1) and glibenclamide-treated rats. Histological observation of the pancreas sections of the rats in the DC group showed scanty number of small sized islets of Langerhans which were scattered within the acini. The islets cells have pyknotic nuclei and scanty eosinophilic cytoplasm. Fibrosis was noted in some areas while sections of the kidneys showed normal histological structure (glomeruli, renal tubules, blood vessels and interstitium) of the kidneys the NC, DM, and treated rats. In conclusion, the outcome of this study showed that ElE:OsC (2:1) and ElE:PgC (2:1) plant extracts could serve as potential alternatives for the treatment and control of diabetes mellitus and its related complications in diabetes mellitus rats. |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Faculty of Industrial Sciences and Technology |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Universities and colleges |
| General subdivision |
Dissertations |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Theses |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Thesis |